{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:26:21Z","timestamp":1793521581468,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.toxicon.2021.05.012","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T02:34:17Z","timestamp":1622514857000},"page":"60-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Analgesic effect of botulinum toxin in children with cerebral palsy: A systematic review"],"prefix":"10.1016","volume":"199","author":[{"given":"Stramkauskaite","family":"Almina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylaite","family":"Karile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasauskiene","family":"Audrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakaniene","family":"Indre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2021.05.012_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/apa.13368","article-title":"Pain in children and adolescents with cerebral palsy: a population-based registry study","volume":"105","author":"Alriksson\u2010Schmidt","year":"2016","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.toxicon.2021.05.012_bib2","first-page":"116","article-title":"Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial","volume":"42","author":"Barwood","year":"2000","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejpn.2017.12.015","article-title":"Quantitative sensory testing profiles in children, adolescents and young adults (6\u201320 years) with cerebral palsy: hints for a neuropathic genesis of pain syndromes","volume":"22","author":"Blankenburg","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib5","article-title":"Birth prevalence of cerebral palsy: a population-based study","volume":"137","author":"Braun","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.toxicon.2021.05.012_bib6","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archpedi.157.12.1219","article-title":"The incidence of pain in children with severe cognitive impairments","volume":"157","author":"Breau","year":"2003","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.toxicon.2021.05.012_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejpn.2010.04.006","article-title":"A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE","volume":"15","author":"Chal\u00e9at-Valayer","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ridd.2012.11.025","article-title":"The cerebral palsy quality of life for children (CP QOL-child): evidence of construct validity","volume":"34","author":"Chen","year":"2013","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.toxicon.2021.05.012_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3349\/ymj.2018.59.5.677","article-title":"Functional communication profiles in children with cerebral palsy in relation to gross motor function and manual and intellectual ability","volume":"59","author":"Choi","year":"2018","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.toxicon.2021.05.012_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2014.01.050","article-title":"Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial","volume":"165","author":"Copeland","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.toxicon.2021.05.012_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.apmr.2011.10.019","article-title":"Relationship between gross motor and intellectual function in children with cerebral palsy: a cross-sectional study","volume":"93","author":"Dalvand","year":"2012","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2021.05.012_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ridd.2014.10.043","article-title":"Predictors of participation of adolescents with cerebral palsy: a European multi-centre longitudinal study","volume":"36","author":"Dang","year":"2015","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.toxicon.2021.05.012_bib13","first-page":"26","article-title":"The prevalence, distribution, and effect of pain among adolescents with cerebral palsy","volume":"22","author":"Doralp","year":"2010","journal-title":"Pediatr. Phys. Ther. Off. Publ. Sect. Pediatr. Am. Phys. Ther. Assoc."},{"key":"10.1016\/j.toxicon.2021.05.012_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12883-019-1597-7","article-title":"Pain in children and adolescents with cerebral palsy \u2013 a cross-sectional register study of 3545 individuals","volume":"20","author":"Eriksson","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2106\/JBJS.F.01416","article-title":"Does Botulinum toxin A combined with hip bracing prevent hip displacement in children with cerebral palsy and \"hips-at-risk\"? A randomized, controlled trial","volume":"90","author":"Graham","year":"2008","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.toxicon.2021.05.012_bib16","first-page":"1","article-title":"Cerebral palsy","volume":"2","author":"Graham","year":"2016","journal-title":"Nat. Rev. Dis. Primer"},{"issue":"6","key":"10.1016\/j.toxicon.2021.05.012_bib17","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1002","article-title":"Pain assessment and treatment in children with significant impairment of the central nervous system","volume":"139","author":"Hauer","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.toxicon.2021.05.012_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1468-1331.1999.tb00034.x","article-title":"Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A: the parents' view of functional outcome","volume":"6","author":"Heinen","year":"1999","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib19","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1177\/0883073814533196","article-title":"Rationale for using botulinum toxin A as an adjunct to upper limb rehabilitation in children with cerebral palsy","volume":"29","author":"Hoare","year":"2014","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1469-8749.2004.tb00428.x","article-title":"Clinical validation of the paediatric pain profile","volume":"46","author":"Hunt","year":"2004","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ocl.2017.11.006","article-title":"Hip surveillance in children with cerebral palsy","volume":"49","author":"Huser","year":"2018","journal-title":"Orthop. Clin. N. Am."},{"key":"10.1016\/j.toxicon.2021.05.012_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/17453674.2019.1627116","article-title":"Primary surgery to prevent hip dislocation in children with cerebral palsy in Sweden: a minimum 5-year follow-up by the national surveillance program (CPUP)","volume":"90","author":"Kiapekos","year":"2019","journal-title":"Acta Orthop."},{"key":"10.1016\/j.toxicon.2021.05.012_bib23","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.toxicon.2021.05.012_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/BPO.0000000000001347","article-title":"Natural history of spastic hip disease","volume":"39","author":"Lins","year":"2019","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.toxicon.2021.05.012_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1469-8749.2009.03315.x","article-title":"Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy","volume":"51","author":"Lundy","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.annepidem.2016.01.001","article-title":"Prevalence of cerebral palsy and intellectual disability among children identified in two U.S. National Surveys, 2011\u20132013","volume":"26","author":"Maenner","year":"2016","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/toxins10040162","article-title":"Analgesic effects of botulinum toxin in children with CP","volume":"10","author":"Michelsen","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2021.05.012_bib28","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/dmcn.13480","article-title":"Prevention of hip displacement in children with cerebral palsy: a systematic review","volume":"59","author":"Miller","year":"2017","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib29","first-page":"349","article-title":"Botulinum toxin type A in subjects with spastic cerebral palsy from Eastern India","volume":"8","author":"Misra","year":"2010","journal-title":"J. Pediatr. Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40272-019-00344-8","article-title":"Botulinum toxin in the management of children with cerebral palsy","volume":"21","author":"Multani","year":"2019","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.toxicon.2021.05.012_bib31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1469-8749.2006.tb01227.x","article-title":"Initial development and validation of the caregiver Priorities and child health Index of life with Disabilities (CPCHILD)","volume":"48","author":"Narayanan","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib32","series-title":"Levels of evidence","year":"2016"},{"key":"10.1016\/j.toxicon.2021.05.012_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/09638280500158422","article-title":"The epidemiology of cerebral palsy: incidence, impairments and risk factors","volume":"28","author":"Odding","year":"2006","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.toxicon.2021.05.012_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/dmcn.12080","article-title":"An update on the prevalence of cerebral palsy: a systematic review and meta-analysis","volume":"55","author":"Oskoui","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/dmcn.14088","article-title":"Management of pain in children and adolescents with cerebral palsy: a systematic review","volume":"61","author":"Ostojic","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.apmr.2019.08.475","article-title":"Acute and chronic pain in children and adolescents with cerebral palsy: prevalence, interference, and management","volume":"101","author":"Ostojic","year":"2020","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2021.05.012_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clp.2006.03.011","article-title":"The descriptive epidemiology of cerebral palsy","volume":"33","author":"Paneth","year":"2006","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/toxins5030524","article-title":"Safety of botulinum toxin A in children and adolescents with cerebral palsy in a pragmatic setting","volume":"5","author":"Papavasiliou","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2021.05.012_bib39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1651-2227.2009.01626.x","article-title":"Pain in children with cerebral palsy: a cross-sectional multicentre European study","volume":"99","author":"Parkinson","year":"2010","journal-title":"Acta Paediatr. Oslo Nor"},{"key":"10.1016\/j.toxicon.2021.05.012_bib41","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/bmj.332.7544.772","article-title":"Hip dislocation in cerebral palsy","volume":"332","author":"Pountney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.toxicon.2021.05.012_bib42","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1469-8749.2011.04070.x","article-title":"Characteristics of recurrent musculoskeletal pain in children with cerebral palsy aged 8 to 18 years","volume":"53","author":"Ramstad","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib43","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3109\/09638288.2012.656794","article-title":"Mental health, health related quality of life and recurrent musculoskeletal pain in children with cerebral palsy 8-18 years old","volume":"34","author":"Ramstad","year":"2012","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.toxicon.2021.05.012_bib44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/AJP.0b013e31819a6d07","article-title":"Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy","volume":"25","author":"Rivard","year":"2009","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.toxicon.2021.05.012_bib45","first-page":"8","article-title":"A report: the definition and classification of cerebral palsy April 2006","volume":"109","author":"Rosenbaum","year":"2007","journal-title":"Dev. Med. Child Neurol. Suppl."},{"key":"10.1016\/j.toxicon.2021.05.012_bib46","doi-asserted-by":"crossref","first-page":"e1149","DOI":"10.1542\/peds.2006-2425","article-title":"Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial","volume":"119","author":"Russo","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.toxicon.2021.05.012_bib47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.toxicon.2018.01.017","article-title":"Botulinum toxin treatment of pain syndromes -an evidence based review","volume":"147","author":"Safarpour","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.05.012_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2340\/16501977-2369","article-title":"Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy","volume":"50","author":"Schasfoort","year":"2018","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.toxicon.2021.05.012_bib49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dmcn.13026","article-title":"A special supplement: findings from the Australian Cerebral Palsy Register, birth years 1993 to 2006","volume":"58","author":"Smithers-Sheedy","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib50","unstructured":"Systematic Reviews | AACPDM - American Academy for Cerebral Palsy and Developmental Medicine [WWW Document], n.d. URL https:\/\/www.aacpdm.org\/education\/systematic-reviews (accessed 4.18.21)."},{"key":"10.1016\/j.toxicon.2021.05.012_bib51","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/apmr.2002.27466","article-title":"The reliability and validity of pain interference measures in persons with cerebral palsy","volume":"83","author":"Tyler","year":"2002","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2021.05.012_bib52","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bja.2019.01.040","article-title":"Pain, placebo, and test of treatment efficacy: a narrative review","volume":"123","author":"Vase","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.toxicon.2021.05.012_bib53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejpn.2007.08.002","article-title":"Visual Analogue Scale to score the effects of Botulinum Toxin A treatment in children with cerebral palsy in daily clinical practice","volume":"12","author":"Vles","year":"2008","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib54","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/dmcn.14145","article-title":"Preoperative botulinum neurotoxin A for children with bilateral cerebral palsy undergoing major hip surgery: a randomized double-blind placebo-controlled trial","volume":"61","author":"Will","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.toxicon.2021.05.012_bib55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/09638288.2013.782356","article-title":"Pain, pain anxiety and emotional and behavioural problems in children with cerebral palsy","volume":"36","author":"Yamaguchi","year":"2014","journal-title":"Disabil. Rehabil."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010121001598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010121001598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:18:28Z","timestamp":1758575908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010121001598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":53,"alternative-id":["S0041010121001598"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.05.012","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesic effect of botulinum toxin in children with cerebral palsy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}